# ROCK CREEK PHARMACEUTICALS, INC.

ROCK CREEK PHARMACEUTICALS, INC. is a company headquartered in Sarasota, FL, United States.

## Company overview

- **Legal name:** ROCK CREEK PHARMACEUTICALS, INC.
- **Former names in filing history:** STAR SCIENTIFIC INC (1999-05-10 to 2014-06-02); EYE TECHNOLOGY INC (1996-09-11 to 1998-02-17)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** Sarasota, FL, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000776008

## About

ROCK CREEK PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000776008, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2016-03-22, it reported net income of USD -6,845,000; total assets of USD 19,547,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Net income:** -$6.8M (USD -6,845,000)
- **Total assets:** $19.5M (USD 19,547,000)
- **Cash and equivalents:** $493,000 (USD 493,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Net income:** -$38.5M (USD -38,517,000)
- **Total assets:** $8.9M (USD 8,917,000)
- **Cash and equivalents:** $395,000 (USD 395,000)
- **Operating cash flow:** -$16.5M (USD -16,478,000)

### FY2013 (period ended 2013-12-31)

- **Net income:** -$32.8M (USD -32,834,000)
- **Total assets:** $11.0M (USD 10,952,000)
- **Cash and equivalents:** $3.9M (USD 3,881,000)
- **Operating cash flow:** -$26.0M (USD -26,002,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-12-31)

- **Net income:** -$22.9M (USD -22,853,000)
- **Total assets:** $31.9M (USD 31,924,000)
- **Cash and equivalents:** $23.1M (USD 23,121,000)
- **Operating cash flow:** -$17.7M (USD -17,702,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2016-09-28 — period 2016-09-28 — FORM 8-K
- Form 8-K — filed 2016-08-29 — period 2016-08-24 — FORM 8-K
- Form 8-K — filed 2016-08-17 — period 2016-08-12 — FORM 8-K
- Form 10-Q — filed 2016-08-10 — period 2016-06-30 — FORM 10-Q
- Form DEF 14A — filed 2016-07-22 — period 2016-08-12 — DEF 14A
- Form 8-K — filed 2016-07-08 — period 2016-07-01 — FORM 8-K
- Form 8-K — filed 2016-07-08 — period 2016-07-07 — FORM 8-K
- Form 8-K — filed 2016-05-16 — period 2016-05-16 — 8-K
- Form 10-Q — filed 2016-05-16 — period 2016-03-31 — FORM 10-Q
- Form 10-K/A — filed 2016-04-29 — period 2015-12-31 — FORM 10-K/A
- Form 8-K — filed 2016-04-05 — period 2016-03-30 — FORM 8-K
- Form 8-K — filed 2016-03-31 — period 2016-03-30 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/rock-creek-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology